Heart Transplantation Therapeutic Pipeline Review H2 2014 Report at ReportsnReports.com

Share Article

ReportsnReports.com adds “Heart Transplantation - Pipeline Review, H2 2014” to its store. The report provides an overview of the Heart Transplantation therapeutic pipeline.

Heart Transplantation Therapeutic Pipeline

Heart Transplantation Therapeutic Pipeline

The report "Heart Transplantation Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Heart Transplantation. A heart transplant is a surgical transplant procedure performed on patients with end-stage heart failure. End-stage heart failure is a disease in which the heart muscle is failing rigorously in its attempt to pump blood through the body, and in which all other available treatments are no longer helping to improve the heart's function. Some causes of heart failure includes Heart attack, viral infection of the heart muscle, hypertension, Valvular heart disease, Congenital heart conditions, Cardiac arrhythmias, Pulmonary hypertension, Alcoholism or drug abuse, Chronic lung diseases, Anemia. Heart transplantation is not considered to be a treatment for heart disease, but a life-saving cure proposed to improve the quality of life for recipients. Complete Report is Available @ http://www.reportsnreports.com/reports/321907-heart-transplantation-pipeline-review-h2-2014.html .

It also reviews key players involved in the therapeutic development for Heart Transplantation and special features on late-stage and discontinued projects. Companies discussed in this Heart Transplantation Pipeline Review H2 2014 report include Astellas Pharma Inc., Merck & Co., Inc., Viron Therapeutics, Inc.

Drugs profile discussed in this Heart Transplantation Pipeline Review H2 2014 report include AS-2521780, SCH-546738, VT-111a, VT-214. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=321907 .

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Heart Transplantation Overview 6
Therapeutics Development 7
Pipeline Products for Heart Transplantation - Overview 7
Pipeline Products for Heart Transplantation - Comparative Analysis 8
Heart Transplantation - Therapeutics under Development by Companies 9
Heart Transplantation - Therapeutics under Investigation by Universities/Institutes 10
Heart Transplantation - Pipeline Products Glance 11
Early Stage Products 11
Heart Transplantation - Products under Development by Companies 12
Heart Transplantation - Products under Investigation by Universities/Institutes 13
Heart Transplantation - Companies Involved in Therapeutics Development 14
Astellas Pharma Inc. 14
Merck & Co., Inc. 15
Viron Therapeutics, Inc. 16
Heart Transplantation - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Molecule Type 22
Drug Profiles 23
AS-2521780 - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SCH-546738 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecules to Inhibit C-Rel for Central Nervous System, Immunology, Musculoskeletal, Oncology, Respiratory and Metabolic Disorders - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
VT-111a - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
VT-214 - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Heart Transplantation - Recent Pipeline Updates 29
Heart Transplantation - Dormant Projects 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Number of Products under Development for Heart Transplantation, H2 2014 7
Number of Products under Development for Heart Transplantation - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Number of Products under Investigation by Universities/Institutes, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Products under Development by Companies, H2 2014 12
Products under Investigation by Universities/Institutes, H2 2014 13
Heart Transplantation - Pipeline by Astellas Pharma Inc., H2 2014 14
Heart Transplantation - Pipeline by Merck & Co., Inc., H2 2014 15
Heart Transplantation - Pipeline by Viron Therapeutics, Inc., H2 2014 16
Assessment by Monotherapy Products, H2 2014 17
Number of Products by Stage and Target, H2 2014 19
Number of Products by Stage and Mechanism of Action, H2 2014 21
Number of Products by Stage and Molecule Type, H2 2014 22
Heart Transplantation Therapeutics - Recent Pipeline Updates, H2 2014 29
Heart Transplantation - Dormant Projects, H2 2014 30

List of Figures
Number of Products under Development for Heart Transplantation - Comparative Analysis, H2 2014 8
Comparative Analysis by Early Stage Products, H2 2014 11
Number of Products by Top 10 Targets, H2 2014 18
Number of Products by Stage and Top 10 Targets, H2 2014 19
Number of Products by Top 10 Mechanism of Actions, H2 2014 20
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 21
Number of Products by Top 10 Molecule Types, H2 2014 22

Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
ReportsnReports
+1 (888) 391-5441
Email >
@LifeSciReports
Follow >
Sandler Research
since: 04/2014
Like >
Follow us on
Visit website